Clinical Trial Update: Fruquintinib in Patients With Metastatic Colorectal Cancer

View source ↗

Summary

Clinical trial update indicates a study evaluating Fruquintinib for metastatic colorectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Fruquintinib (fruquintinib)

Snippet

Sponsor: iOMEDICO AG | Conditions: Metastatic Colorectal Cancer (mCRC) | Status: RECRUITING